Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
1.550
-0.080 (-4.91%)
At close: Aug 1, 2025, 4:00 PM
1.560
+0.010 (0.65%)
Pre-market: Aug 4, 2025, 6:16 AM EDT
Verve Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated May 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.